TSJCI Annual Report 2021

Table of Contents	2
Patients	4
People	4
ClinicalCare	4
Radiology	4
Histopathology, Cytology, CancerMolecular Diagnostics, Immunology	4
Research	4
Education	4
Directors’ Introduction	6
Trinity St James’s CancerInstitute Governance Structure	8
Section 1.0 Clinical Care	8
Section 1.1 Adolescent and Young Adult Cancers Programme (AYA)	9
Section 1.2 Cancer Genetics	10
Section 1.3 Dermatology/Plastic Surgery/Dermatopathology –Skin Cancers	12
Section 1.4 Endocrinology – Thyroid Cancers	14
Section 1.5 Haematology Service	14
Section 1.6 Histopathology, Cytology, Cancer MolecularDiagnostics, Immunology	16
Section 1.7 Medical Oncology	18
Section 1.8 Palliative Care	18
Section 1.9 Psychological Medicine	18
Section 1.10 Volunteer Programme	18
Section 1.11 Pharmacy	20
Section 1.12 Radiology	20
Section 1.13 Surgical Oncology	22
Section 2.0 Cancer Clinical Trials	24
2.1 Key Developments during 2021	24
2.2 Key Priorities for 2022	24
Section 3.0 Health And SocialCare Professions	26
3.1 Key Developments during 2021	26
3.2 Key Priorities for 2022	26
Section 4.0 Nursing	28
4.1 Key Developments during 2021	28
4.2 Key Priorities for 2022	28
Section 5.0 St Luke’s RadiationOncology Network	30
5.1 Clinical Care Highlights	30
5.2 SLRON Activity	30
5.3 Key Developments during 2021	30
5.4 Key Priorities for 2022	30
Section 6.0 Education	30
6.1 Key Developments during 2021	30
6.2 Key Priorities for 2022	32
Section 7.0 Research	32
7.1 Key Developments during 2021	32
7.2 Key Priorities for 2022	34
Section 8.0 Quality	34
8.1 Key Developments during 2021	34
8.2 Key Priorities for 2022	34
Section 9.0 Patient Representative Group	36
9.1 Key Developments during 2021	36
9.2 Key Priorities for 2022	36
Section 10 Special Circumstances	36
10.1 Information Management Systems (IMS) Cyber Attack	36
10.2 COVID-19	36
Appendix 1 Glossary Of Terms	38

Made with FlippingBook

RkJQdWJsaXNoZXIy MTQzNDk=